September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […] KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today […] GEORGE TOWN, Cayman Islands–(BUSINESS WIRE)August 09, 2018 –Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”) a wholly owned subsidiary of Highland Therapeutics […] July 30, 2018 — The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use […] The FDA is trying to figure out if more prescription meds can be sold OTC. With the rising cost of […] The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which […] RALEIGH, N.C., July 3, 2018 — Merz North America announced today that the U.S. Food and Drug Administration (FDA) has […] June 25, 2018 — The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment […] (HealthDay)—The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and […] Guys, guys, guys: sunscreen pills? Are you kidding me? Apparently not, because tons of companies are claiming that taking a […]FDA
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata
FDA Approves Delstrigo
FDA Approves Jornay PM
FDA Approves Azedra
Could Your Medication Soon Be Available Over the Counter?
FDA recalls heart medication valsartan, citing cancer concerns
FDA Approves Xeomin (incobotulinumtoxinA) for Adult Patients with Sialorrhea (Excessive Drooling)
FDA Approves Epidiolex
FDA approves first generic under-the-tongue suboxone
Sunscreen Pills Are Total B.S., According To The FDA
Copyright © 2024